Bioscience Managers
Bioscience Managers Pty Ltd is a venture capital firm founded in 2003 and headquartered in Melbourne, Australia, with an additional office in London, United Kingdom. The firm specializes in investments in mid-stage companies within the healthcare sector, particularly focusing on biotechnology and life sciences. Its investment strategy encompasses areas such as therapeutics, medical devices, diagnostics, and digital health, while emphasizing companies engaged in clinical testing and animal studies. Bioscience Managers aims to provide substantial value to its portfolio companies, leveraging a global, multi-disciplinary team with extensive experience in the bio-based industries. The firm has a proven track record, having participated in over 170 investments and more than 40 IPOs across various markets, including Australia, the United Kingdom, Europe, and North America. Additionally, it offers corporate advisory services through its Phillip Bioscience Advisory arm, supporting healthcare and life sciences companies in navigating complex market dynamics.
Canary Medical Inc. specializes in the development of medical implant and data management devices that facilitate remote patient monitoring and data collection. The company's primary innovation is the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device designed to gather and process medical data without requiring direct physician intervention. Additionally, Canary Medical creates smart medical devices that provide self-reports on patient activity, recovery, and treatment outcomes, thereby enhancing patient compliance. Established in 2013 and headquartered in Vancouver, Canada, the company has also formed a joint venture with BioScience Managers to launch CHARM Informatics, a platform aimed at collecting and monetizing data from implantable and wearable medical devices.
Canary Medical Inc. specializes in the development of medical implant and data management devices that facilitate remote patient monitoring and data collection. The company's primary innovation is the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device designed to gather and process medical data without requiring direct physician intervention. Additionally, Canary Medical creates smart medical devices that provide self-reports on patient activity, recovery, and treatment outcomes, thereby enhancing patient compliance. Established in 2013 and headquartered in Vancouver, Canada, the company has also formed a joint venture with BioScience Managers to launch CHARM Informatics, a platform aimed at collecting and monetizing data from implantable and wearable medical devices.
Rex Bionics Ltd. is a New Zealand-based company that specializes in the development and manufacturing of robotic medical equipment aimed at rehabilitation. Incorporated in 2007, the company produces the REX, a hands-free robotic device designed to assist individuals with mobility impairments in exercising, walking, and standing. Rex Bionics focuses on improving the physical and psychological well-being of people affected by spinal cord injuries, strokes, traumatic brain injuries, and neurodegenerative diseases. The company's primary products include the REX and the REX P (Personal), which cater to both professional neuro-rehabilitation clinics and personal homecare markets. Through innovative technology, Rex Bionics aims to enhance the rehabilitation experience for individuals facing significant mobility challenges.
Avita is a medical company that specializes in regenerative medicine, chronic wounds, and plastic surgery. It provides a novel approach to skin regeneration. Our products provide innovative treatment solutions derived from the regenerative properties of a patient’s own skin.
Saluda Medical Pty Ltd. is a medical device company focused on developing innovative solutions for the neuromodulation industry. The firm is known for its investigational device, Evoke, which features a closed-loop spinal cord stimulation system. This technology measures the spinal cord's response to stimulation and adjusts the stimulation parameters in real-time to optimize therapeutic outcomes for patients. Founded in 2010 and headquartered in Artarmon, Australia, with additional offices in Minnesota and the United Kingdom, Saluda Medical aims to provide effective treatment for chronic neuropathic pain. The company's unique approach involves monitoring each patient's neural fingerprint to automatically tailor electrical stimulation, ensuring that therapy is customized to meet individual needs. Saluda Medical's commitment to advancing medical technology is underpinned by a strong foundation of scientific research and a team of experienced professionals.
Nexvet Australia Pty Ltd, a biopharmaceutical company, develops biological therapies for companion animals. It develops drugs in the areas of chronic pain, immune oncology, chronic inflammation, and allergy. Nexvet Australia Pty Ltd was formerly known as Nexvet Biopharma Pty Ltd. The company was founded in 2010 and is based in Melbourne, Australia with a biopharmaceutical manufacturing facility in Tullamore, Ireland. Nexvet Australia Pty Ltd operates as a subsidiary of Zoetis Inc.
AmpliPhi Biosciences is a biopharmaceutical company dedicated to developing bacteriophage-based therapies for bacterial infections, particularly those caused by drug-resistant strains. By leveraging naturally occurring viruses known as bacteriophages, the company aims to offer an innovative treatment approach that addresses a broad range of bacterial diseases. AmpliPhi has established a drug development and manufacturing platform that facilitates the rapid creation and production of various phage therapies. The initial focus of its research and development efforts is on treating acute and chronic infections in the lung, sinus, and gastrointestinal areas. The company operates in multiple locations, including Richmond, Virginia, Colworth Science Park in the United Kingdom, and near Sydney, Australia.
Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST®, derived from Alchemia’s chemistry expertise.
Adherium (previously known as Nexus6) is a privately owned developer and manufacturer of solutions that help patients and their healthcare professionals monitor and increase patient adherence to prescribed therapies, leading to improved disease management and reduced healthcare costs.
SeaDragon Limited is a New Zealand-based company that specializes in the manufacture and marketing of refined fish oils. Founded in 1986 and located in Nelson, the company processes fish oils into marine bioactive compounds and produces Omega-3 fish oil products. SeaDragon primarily serves health supplement manufacturers, both domestically and internationally, focusing on delivering high-quality fish oil products.
Millenium Biologix Corporation is a biomedical company based in Kingston, Canada, focused on developing and commercializing implantable medical devices and skeletal tissue regeneration products, primarily for orthopedic applications in the United States and Europe. The company offers Skelite, a synthetic bone graft designed for healing and replacement, as well as Primacoll and Peptos, which are products aimed at stimulating bone tissue growth. Additionally, Millenium Biologix has developed ACTES, a cell culture and tissue engineering system that automates the biological processes involved in tissue engineering. Established in 1986, the company continues to innovate in the field of orthopedics.
Millenium Biologix Corporation is a biomedical company based in Kingston, Canada, focused on developing and commercializing implantable medical devices and skeletal tissue regeneration products, primarily for orthopedic applications in the United States and Europe. The company offers Skelite, a synthetic bone graft designed for healing and replacement, as well as Primacoll and Peptos, which are products aimed at stimulating bone tissue growth. Additionally, Millenium Biologix has developed ACTES, a cell culture and tissue engineering system that automates the biological processes involved in tissue engineering. Established in 1986, the company continues to innovate in the field of orthopedics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.